Treatment of benign prostatic hyperplasia using the hardware-software complex “IMEDIS-EXPERT“
AUTHORS : Islamov B.I. | Gotovsky M.Yu. | Meizerov E.E.
RELEVANT UNIVERSITIES : oneInstitute of Theoretical and Experimental Biophysics RAS, Pushchino,
2Center “IMEDIS”, 3Federal Scientific Clinical and Experimental Center for Traditional Methods of
Diagnostics and Treatment of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
YEAR : 2005
Benign prostatic hyperplasia (BPH) is a disease resulting from the
proliferation of the periurethral prostate gland, leading to obstruction of the lower
urinary tract.
At the age of 50, 50% of men have changes characteristic of
BPH, at the age of 80 – in 90%.
Testosterone increases with age
under the influence
5-α-reductase enzyme activity.
5-α-reductase is converted to
dihydrotestosterone.
